Bristol-Myers Squibb
BMY
BMY
2,319 hedge funds and large institutions have $84.2B invested in Bristol-Myers Squibb in 2024 Q1 according to their latest regulatory filings, with 169 funds opening new positions, 930 increasing their positions, 964 reducing their positions, and 176 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less first-time investments, than exits
New positions opened: 169 | Existing positions closed: 176
1% less funds holding
Funds holding: 2,351 → 2,319 (-32)
17% less funds holding in top 10
Funds holding in top 10: 24 → 20 (-4)
Holders
2,319
Holding in Top 10
20
Calls
$1.56B
Puts
$1.23B
Top Buyers
| 1 | +$2.3B | |
| 2 | +$470M | |
| 3 | +$363M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$296M |
| 5 |
VanEck Associates
New York
|
+$212M |
Top Sellers
| 1 | -$1.6B | |
| 2 | -$656M | |
| 3 | -$433M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$351M |
| 5 |
BlackRock
New York
|
-$301M |